作者：
Insel,T.R. [1]
;
Voon,V. [2]
;
Nye,J.S. [3]
;
Brown,V.J. [4]
;
Altevogt,B.M. [5]
;
Bullmore,E.T. [6]
;
Goodwin,G.M. [7]
;
Howard,R.J. [8]
;
Kupfer,D.J. [9]
;
Malloch,G. [10]
;
Marston,H.M. [11]
;
Nutt,D.J. [12]
;
Robbins,T.W. [13]
;
Stahl,S.M. [14]
;
Tricklebank,M.D. [15]
;
Williams,J.H. [16]
;
Sahakian,B.J.
作者单位：
MRC, Wellcome Trust Behavioral and Clinical Neuroscience Institute, University of Cambridge
[1]
TPP Global Development, Edinburgh, United Kingdom
[2]
Centre for Pharmacology and Therapeutics, Division of Experimental Medicine, Imperial College
[3]
School of Psychology and Neuroscience, St Andrews University, St Andrews, United Kingdom
[4]
Institute of Medicine, Forum on Neuroscience and Nervous System Disorders, Washington, DC, United
[5]
University of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburg, PA, United States
[6]
Eli Lilly and Co Ltd, Windlesham, United Kingdom
[7]
Neuroscience, Janssen Pharmaceutical of Johnson and Johnson, Titusville, NJ, United States
[8]
National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States
[9]
Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom, MRC, Wellcome Trust
[10]
Department of Psychiatry, University of Oxford, Oxford, United Kingdom
[11]
Glaxo Smith Kline, Clinical Unit, Addenbrookes Hospital, Cambridge, United Kingdom
[12]
Wellcome Trust, United Kingdom
[13]
Royal College of Psychiatrists and Institute of Psychiatry, Kings College London, London, United
[14]
Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom, Department of
[15]
Medical Research Council, United Kingdom
[16]
发布时间
2014-04-25
换一批
